M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Return to Archives
New Search
Tranzyme Pharma to present clinical results on ulimorelin (TZP-101) at Digestive Disease Week 2010
Biopharmaceutical company Tranzyme Pharma said on Friday that in May the company will present data from the Phase 2 clinical trial of ulimorelin (TZP-101) for the treatment of severe gastroparesis.
The study results have been selected for oral presentation at Digestive Disease Week (DDW)...
If you want to view the full text of this story, you must first purchase archive retrieval credits.